gvtcx

SMA Newborn Screening Kits

NHS Greater Glasgow and Clyde Published 2 Apr 2026 Public Contracts Scotland

key details

Statuscomplete
Category (CPV) 33696500
RegionScotland
Procedurelimited
OCIDocds-h6vhtk-066e98

Award

SupplierValueDateStatus
Labsystems Diagnostics OY · · active

description

The Scottish Newborn Screening Laboratory has been commissioned to participate in the in-service evaluation for Spinal Muscular Atrophy (SMA) organised by the National Screening Committee. NHSGG&C require newborn screening kits that measure both SMN1 and SMN2 genes simultaneously. The SMN2 copy number must be screened for at the same time as the SMN1 deletion in keeping with the Scottish screening protocol. The requirement is to screen dried blood spot samples from newborn babies for Spinal Muscular Atrophy (SMA).

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
19 Mar 2026 Voluntary ex-ante transparency (F15) Earlier regulations 025039-2026
2 Apr 2026 Contract award notice (F03) Earlier regulations 031045-2026

more from NHS Greater Glasgow and Clyde

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Public Contracts Scotland. Contact details for named individuals are not reproduced on this site.